Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Martin Marszalek is a leading urologic oncologist whose research centers on optimizing surgical outcomes for patients with kidney cancer, particularly through nephron-sparing surgery (partial nephrectomy). His major contributions lie in understanding and reducing the risk of positive surgical margins—cancer cells left behind after tumor removal—a critical factor in preventing disease recurrence. With over 225 citations, his seminal 2011 work on positive surgical margins after nephron-sparing surgery established foundational knowledge in the field. Dr. Marszalek has since been at the forefront of multicenter international collaborations, including the Surface-Intermediate-Base (SIB) Margin Score Consortium, which developed a standardized system to report resection techniques and predict margin status. His prospective studies, such as the 2019 analysis of over 90 citations examining how resection technique impacts perioperative outcomes and acute kidney injury, have directly influenced surgical practice. Notably, his work on the "Trifecta" outcomes—achieving negative margins, minimal complications, and preserved renal function—for highly complex renal masses has set new benchmarks for surgical success. Through these efforts, Dr. Marszalek has advanced the precision of kidney cancer surgery, improving both oncologic and functional outcomes for patients worldwide.